Update on Idiopathic Intracranial Hypertension

Area of Science:

• Neurology
• Ophthalmology
• Radiology

Background:

• Idiopathic intracranial hypertension (IIH) is a neurological disorder characterized by increased intracranial pressure without a clear cause.
• Accurate diagnosis and effective management are crucial for preventing vision loss and improving patient quality of life.

Purpose of the Study:

• To review recent advancements in the diagnosis, management, and understanding of idiopathic intracranial hypertension (IIH).
• To highlight key developments in diagnostic techniques and therapeutic strategies for IIH.

Main Methods:

• Review of current literature on idiopathic intracranial hypertension (IIH).
• Analysis of noninvasive imaging techniques (ultrasound, MRI, MR venography) for IIH diagnosis.
• Evaluation of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) findings on acetazolamide and weight loss.

Main Results:

• Noninvasive imaging aids in detecting characteristic IIH features like transverse sinus stenosis.
• The IIHTT confirmed acetazolamide plus weight loss significantly improves visual function, papilledema, CSF pressure, and quality of life.
• Surgical interventions including CSF shunting and optic nerve sheath fenestration offer variable success rates.

Conclusions:

• Recent advances have improved the diagnosis and management of idiopathic intracranial hypertension (IIH).
• Combined medical (acetazolamide) and lifestyle (weight loss) interventions are effective for IIH.
• Further research is needed to elucidate IIH pathogenesis and develop novel targeted therapies.